Journal profile

Toxicologic pathology

Publisher: Sage Publications
ISSN0192-6233 | 0094-1824 | 1533-1601 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.09
Citation rate 2.61 234 total citations
h5-index 22 h5 depth signal
Cited share 70.0% 63 of 90
Total citations 234 Citation footprint
Metric signal 2.39 External metric anchor
Self-citation 21.8% 51 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 628
United Kingdom 110
Switzerland 97
Germany 93
Japan 74

Citing Fields of Research

Pharmacology & Toxicology 329
Clinical Laboratory Science 126
Molecular & Cellular Toxicology 110
Immunology 50
Nervous System Disorders 49

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 4,498 Articles tracked across the journal lifetime
Indexed publication set 90 63 cited publications
Last 12 months 66 5.5 publications/month
Open access share 12.1% 8 OA publications in the last year
Leading citing country United States 628 citing publications
Leading citing field Pharmacology & Toxicology 329 citing publications
Latest tracked publication 15 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v12n1, 1984-
PubMed
v12n1, 1984-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Pharmacology & Toxicology Clinical Laboratory Science Molecular & Cellular Toxicology Mass Spectrometry Neurodegenerative Disorders

Issuing & Sponsoring Bodies

Contributor
Society of Pharmacological and Environmental Pathologists (U.S.)
Contributor
Society of Toxicologic Pathologists (U.S.)
Contributor
Society of Toxicologic Pathology

Broad Categories

Pathology Toxicology Pharmacology & Toxicology Viral Identification & Phylogenetics Medical Ethics Mass Spectrometry Musculoskeletal Disorders Clinical Laboratory Science

MeSH Descriptors

Environmental Pollutants Pathology Pharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Kirstin Barnhart, Brad Bolon, Laura Boone et al.
Replacement of concurrent control groups (CCG) with virtual control groups (VCG) has been advocated as a strategy to reduce animal use in nonclinical toxicity testing. This “Points to Consider” paper examines VCG utility as it impacts to...
04
Nadine Stokar-Regenscheit, Brian Berridge, Julia Kühnlenz et al.
In April 2025, the US Food and Drug Administration (FDA) introduced a bold roadmap to phase out animal testing in drug development by promoting the integration of New Approach Methodologies (NAMs), beginning with monoclonal antibodies (m...
05
Theresa C. Brömel, Barbara Lenz, Rachel Neff et al.
Intraocular inflammation (IOI) following intravitreal (IVT) administration of large molecules (LM) is commonly seen in preclinical species and often relates to the presence of systemic anti-drug antibodies (ADA) as a reaction to the appl...
06
Smitha P. S. Pillai, Keith Mansfield, Ricardo de Miguel et al.
Drug-induced taste dysfunctions are an underrecognized yet clinically significant class of adverse effects that can substantially impair patients’ quality of life and compromise adherence to therapeutic regimens. Despite the potential fo...
08
Antonia Morey-Matamalas, Davide Corbetta, Agnieszka Barc et al.
Mononuclear cell infiltrates (MCIs) and inflammation in the central nervous system (CNS) can be challenging in nonclinical studies, particularly in nonrodent species. A retrospective study was performed to determine the incidences of spo...

Bibliographical & Catalog Notes

Imprint varies.

Also issued online.

Official publication of the Society of Pharmacological and Environmental Pathologists; for <1982-> by Society of Toxicologic Pathologists (U.S.); <2005-> by the Society of Toxicologic Pathology.

Vol. 15, no. 1 (1987)19890816 Notice published Printed on acid-free paper